The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Real World Evidence Solutions-Global Market Insights and Sales Trends 2025

Real World Evidence Solutions-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1846007

No of Pages : 101

Ask Your Query

Synopsis

Real World Evidence is a worldwide trend in Health and Life Sciences. New kinds of data, such as electronic health records and data mining tools are now available and allow us to extract information and knowledge. We can detect medical treatment costs, treatment efficiency (cost, benefits, and risks), references to drugs, side effects, or long-term results.

The global Real World Evidence Solutions market size is expected to reach US$ 1989.7 million by 2029, growing at a CAGR of 12.0% from 2023 to 2029. The market is mainly driven by the significant applications of Real World Evidence Solutions in various end use industries.

The expanding demands from the Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers and Others, are propelling Real World Evidence Solutions market. Clinical Setting Data, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Claims Data segment is estimated at % CAGR for the next seven-year period.

In 2017, North America accounted for the largest share of the market, followed by Europe and Asia Pacific. Presence of a favorable regulatory environment, high number of RWE service providers, the presence of a well-established pharmaceutical industry in the region, coupled with the high R&D expenditure, are the major factors responsible for the large share of North America in the global real world evidence market.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Real World Evidence Solutions, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Real World Evidence Solutions market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Real World Evidence Solutions market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Real World Evidence Solutions sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Real World Evidence Solutions covered in this report include Iqvia, IBM, Pharmaceutical Product Development, Parexel, United Health Group, Perkinelmer, Icon, Oracle and Cognizant, etc.

The global Real World Evidence Solutions market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Iqvia
  • IBM
  • Pharmaceutical Product Development
  • Parexel
  • United Health Group
  • Perkinelmer
  • Icon
  • Oracle
  • Cognizant
  • Syneos Health
  • Anthem
  • Clinigen
  • SAS Institute

Global Real World Evidence Solutions market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Real World Evidence Solutions market, Segment by Type:

  • Clinical Setting Data
  • Claims Data
  • Pharmacy Data
  • Patient Powered Data

Global Real World Evidence Solutions market, by Application

  • Pharmaceutical and Medical Device Companies
  • Healthcare Payers
  • Healthcare Providers
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Real World Evidence Solutions companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Real World Evidence Solutions
1.1 Real World Evidence Solutions Market Overview
1.1.1 Real World Evidence Solutions Product Scope
1.1.2 Real World Evidence Solutions Market Status and Outlook
1.2 Global Real World Evidence Solutions Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Real World Evidence Solutions Market Size by Region (2018-2029)
1.4 Global Real World Evidence Solutions Historic Market Size by Region (2018-2023)
1.5 Global Real World Evidence Solutions Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Real World Evidence Solutions Market Size (2018-2029)
1.6.1 North America Real World Evidence Solutions Market Size (2018-2029)
1.6.2 Europe Real World Evidence Solutions Market Size (2018-2029)
1.6.3 Asia-Pacific Real World Evidence Solutions Market Size (2018-2029)
1.6.4 Latin America Real World Evidence Solutions Market Size (2018-2029)
1.6.5 Middle East & Africa Real World Evidence Solutions Market Size (2018-2029)
2 Real World Evidence Solutions Market by Type
2.1 Introduction
2.1.1 Clinical Setting Data
2.1.2 Claims Data
2.1.3 Pharmacy Data
2.1.4 Patient Powered Data
2.2 Global Real World Evidence Solutions Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Real World Evidence Solutions Historic Market Size by Type (2018-2023)
2.2.2 Global Real World Evidence Solutions Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Real World Evidence Solutions Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Real World Evidence Solutions Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Real World Evidence Solutions Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Real World Evidence Solutions Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Real World Evidence Solutions Revenue Breakdown by Type (2018-2029)
3 Real World Evidence Solutions Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical and Medical Device Companies
3.1.2 Healthcare Payers
3.1.3 Healthcare Providers
3.1.4 Others
3.2 Global Real World Evidence Solutions Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Real World Evidence Solutions Historic Market Size by Application (2018-2023)
3.2.2 Global Real World Evidence Solutions Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Real World Evidence Solutions Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Real World Evidence Solutions Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Real World Evidence Solutions Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Real World Evidence Solutions Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Real World Evidence Solutions Revenue Breakdown by Application (2018-2029)
4 Real World Evidence Solutions Competition Analysis by Players
4.1 Global Real World Evidence Solutions Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Real World Evidence Solutions as of 2022)
4.3 Date of Key Players Enter into Real World Evidence Solutions Market
4.4 Global Top Players Real World Evidence Solutions Headquarters and Area Served
4.5 Key Players Real World Evidence Solutions Product Solution and Service
4.6 Competitive Status
4.6.1 Real World Evidence Solutions Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Iqvia
5.1.1 Iqvia Profile
5.1.2 Iqvia Main Business
5.1.3 Iqvia Real World Evidence Solutions Products, Services and Solutions
5.1.4 Iqvia Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.1.5 Iqvia Recent Developments
5.2 IBM
5.2.1 IBM Profile
5.2.2 IBM Main Business
5.2.3 IBM Real World Evidence Solutions Products, Services and Solutions
5.2.4 IBM Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.2.5 IBM Recent Developments
5.3 Pharmaceutical Product Development
5.3.1 Pharmaceutical Product Development Profile
5.3.2 Pharmaceutical Product Development Main Business
5.3.3 Pharmaceutical Product Development Real World Evidence Solutions Products, Services and Solutions
5.3.4 Pharmaceutical Product Development Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.3.5 Parexel Recent Developments
5.4 Parexel
5.4.1 Parexel Profile
5.4.2 Parexel Main Business
5.4.3 Parexel Real World Evidence Solutions Products, Services and Solutions
5.4.4 Parexel Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.4.5 Parexel Recent Developments
5.5 United Health Group
5.5.1 United Health Group Profile
5.5.2 United Health Group Main Business
5.5.3 United Health Group Real World Evidence Solutions Products, Services and Solutions
5.5.4 United Health Group Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.5.5 United Health Group Recent Developments
5.6 Perkinelmer
5.6.1 Perkinelmer Profile
5.6.2 Perkinelmer Main Business
5.6.3 Perkinelmer Real World Evidence Solutions Products, Services and Solutions
5.6.4 Perkinelmer Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.6.5 Perkinelmer Recent Developments
5.7 Icon
5.7.1 Icon Profile
5.7.2 Icon Main Business
5.7.3 Icon Real World Evidence Solutions Products, Services and Solutions
5.7.4 Icon Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.7.5 Icon Recent Developments
5.8 Oracle
5.8.1 Oracle Profile
5.8.2 Oracle Main Business
5.8.3 Oracle Real World Evidence Solutions Products, Services and Solutions
5.8.4 Oracle Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.8.5 Oracle Recent Developments
5.9 Cognizant
5.9.1 Cognizant Profile
5.9.2 Cognizant Main Business
5.9.3 Cognizant Real World Evidence Solutions Products, Services and Solutions
5.9.4 Cognizant Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.9.5 Cognizant Recent Developments
5.10 Syneos Health
5.10.1 Syneos Health Profile
5.10.2 Syneos Health Main Business
5.10.3 Syneos Health Real World Evidence Solutions Products, Services and Solutions
5.10.4 Syneos Health Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.10.5 Syneos Health Recent Developments
5.11 Anthem
5.11.1 Anthem Profile
5.11.2 Anthem Main Business
5.11.3 Anthem Real World Evidence Solutions Products, Services and Solutions
5.11.4 Anthem Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.11.5 Anthem Recent Developments
5.12 Clinigen
5.12.1 Clinigen Profile
5.12.2 Clinigen Main Business
5.12.3 Clinigen Real World Evidence Solutions Products, Services and Solutions
5.12.4 Clinigen Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.12.5 Clinigen Recent Developments
5.13 SAS Institute
5.13.1 SAS Institute Profile
5.13.2 SAS Institute Main Business
5.13.3 SAS Institute Real World Evidence Solutions Products, Services and Solutions
5.13.4 SAS Institute Real World Evidence Solutions Revenue (US$ Million) & (2018-2023)
5.13.5 SAS Institute Recent Developments
6 North America
6.1 North America Real World Evidence Solutions Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Real World Evidence Solutions Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Real World Evidence Solutions Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Real World Evidence Solutions Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Real World Evidence Solutions Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Real World Evidence Solutions Market Dynamics
11.1 Real World Evidence Solutions Industry Trends
11.2 Real World Evidence Solutions Market Drivers
11.3 Real World Evidence Solutions Market Challenges
11.4 Real World Evidence Solutions Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock